- Home
- EPOW vs CRIS Comparison
EPOW vs CRIS Comparison
Compare EPOW & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EPOW
- CRIS
- Stock Information
- Founded
- EPOW 2014
- CRIS 2000
- Country
- EPOW China
- CRIS United States
- Employees
- EPOW N/A
- CRIS N/A
- Industry
- EPOW Business Services
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- EPOW Consumer Discretionary
- CRIS Health Care
- Exchange
- EPOW Nasdaq
- CRIS Nasdaq
- Market Cap
- EPOW 24.1M
- CRIS 22.9M
- IPO Year
- EPOW 2021
- CRIS 2000
- Fundamental
- Price
- EPOW $0.88
- CRIS $1.71
- Analyst Decision
- EPOW
- CRIS Strong Buy
- Analyst Count
- EPOW 0
- CRIS 2
- Target Price
- EPOW N/A
- CRIS $16.50
- AVG Volume (30 Days)
- EPOW 14.6K
- CRIS 72.5K
- Earning Date
- EPOW 05-15-2025
- CRIS 08-05-2025
- Dividend Yield
- EPOW N/A
- CRIS N/A
- EPS Growth
- EPOW N/A
- CRIS N/A
- EPS
- EPOW N/A
- CRIS N/A
- Revenue
- EPOW $64,997,741.00
- CRIS $11,405,000.00
- Revenue This Year
- EPOW N/A
- CRIS $1.41
- Revenue Next Year
- EPOW N/A
- CRIS $7.46
- P/E Ratio
- EPOW N/A
- CRIS N/A
- Revenue Growth
- EPOW 44.28
- CRIS 12.24
- 52 Week Low
- EPOW $0.70
- CRIS $1.02
- 52 Week High
- EPOW $1.36
- CRIS $6.44
- Technical
- Relative Strength Index (RSI)
- EPOW 44.96
- CRIS 50.40
- Support Level
- EPOW $0.86
- CRIS $1.63
- Resistance Level
- EPOW $1.00
- CRIS $1.95
- Average True Range (ATR)
- EPOW 0.03
- CRIS 0.14
- MACD
- EPOW -0.00
- CRIS 0.02
- Stochastic Oscillator
- EPOW 17.93
- CRIS 50.00
About EPOW Sunrise New Energy Co. Ltd
Sunrise New Energy Co Ltd is engaged in the manufacturing and sale of graphite anode material for EVs and other lithium-ion batteries. The Company's joint venture is in the construction of a manufacturing plant in Guizhou Province. The plant runs on inexpensive electricity from renewable sources that enables the group to be a low-cost and low environmental impact producer of graphite anode material, Its products include GS-1, GS-2, GS-3, GZD-1, GLD-1, and GZ-1.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.